儿童NUP98重排急性髓系白血病9例临床分析
回顾性分析郑州大学第一附属医院2019年1月至2025年6月收治的9例NUP98重排儿童AML,占同期214例儿童AML的4.2%,以女性及M5亚型多见,NUP98::NSD1最常见且常合并FLT3-ITD等突变;诱导缓解率高但易复发,异基因造血干细胞移植可能改善预后。
要点
- NUP98重排儿童AML以女性及M5亚型多见,NUP98::NSD1最常见。
- 常合并FLT3-ITD、NRAS等基因突变。
- 诱导缓解率高但易复发,allo-HSCT可能改善预后。
核心结论
- 本中心NUP98重排儿童AML以女孩多见、M5亚型为主,NUP98::NSD1最常见且易合并FLT3-ITD等突变。
- 诱导缓解率高但易复发,异基因造血干细胞移植可能改善预后。
研究设计与样本
- 回顾性分析2019年1月至2025年6月郑州大学第一附属医院收治的9例新诊断NUP98重排儿童AML。
- 9例占同期确诊214例儿童AML的4.2%,男3例、女6例,中位诊断年龄7岁(范围8个月~14岁)。
主要发现
- 亚型包括M1、M4、M5,以M5最常见(7/9,77.8%)。
- 融合基因以NUP98::NSD1最常见(6/9,66.7%),常合并FLT3-ITD、NRAS等基因突变。
- 6例染色体核型正常,3例染色体核型异常。
- 1个疗程诱导化疗后7例完全缓解(77.8%)。
- 4例巩固治疗2~3个疗程后桥接allo-HSCT均无病存活;余3例继续化疗者均复发后死亡;未完全缓解的2例因疾病进展死亡。
临床怎么用
- 对儿童NUP98重排AML应关注M5亚型及NUP98::NSD1融合基因,并检测FLT3-ITD等合并突变。
- 诱导缓解后宜尽早评估allo-HSCT,可能改善无病生存。
局限性
- 为单中心回顾性病例分析,样本量仅9例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A retrospective case analysis was conducted on nine newly diagnosed pediatric patients with NUP98-rearranged acute myeloid leukemia (AML) who were admitted to the First Affiliated Hospital of Zhengzhou University between January 2019 to June 2025. Nine patients (3 males and 6 females) accounted for 4.2% of the 214 children diagnosed with AML during the same period. The patients' median age at diagnosis was 7 years (range: 8 months to 14 years). This type of AML was classified as M1, M4, and M5, with M5 being the most common subtype (7/9, 77.8%). The most common fusion gene type was NUP98::NSD1 (6/9, 66.7%), which was frequently accompanied by gene mutations such as FLT3-ITD and NRAS. Six cases had normal chromosome karyotypes, whereas the remaining 3 cases had abnormal karyotypes. The complete remission (CR) rate after one course of induction chemotherapy was 77.8% (7/9), and four of the children with CR underwent bridging allogeneic hematopoietic stem cell transplantation (allo-HSCT) after two to three courses of consolidation therapy, and all survived without disease. The remaining three children who continued chemotherapy had a relapse and died; whereas the two children who did not achieve CR died due to disease progression. In conclusion, at this center, pediatric AML with NUP98 rearrangement was more common in females and was often seen in the M5 subtype. NUP98::NSD1 was the most common fusion gene and was often accompanied by gene mutations, such as FLT3-ITD. Although the induction remission rate was high, the disease was prone to relaps. Allo-HSCT may improve the prognosis of these children. 回顾性分析2019年1月至2025年6月郑州大学第一附属医院收治的9例伴有NUP98重排的急性髓系白血病(AML)患儿的临床资料。9例患儿(男3例,女6例)占同期确诊214例儿童AML的4.2%,中位诊断年龄7岁(8个月~14岁)。可见于M1、M4、M5亚型,以M5型最常见(7/9,77.8%)。融合基因类型以NUP98::NSD1最常见(6/9,66.7%),常合并FLT3-ITD、NRAS等基因突变。6例染色体核型正常,3例染色体核型异常。1个疗程诱导化疗后7例完全缓解,其中4例巩固治疗2~3个疗程后桥接异基因造血干细胞移植,均无病存活,余3例继续化疗者均复发后死亡;未完全缓解的2例因疾病进展死亡。本中心伴有NUP98重排儿童AML以女孩多见,M5亚型为主,NUP98::NSD1是最常见的融合基因,易合并FLT3-ITD等基因突变;诱导缓解率高但易复发,异基因造血干细胞移植可能改善其预后。.
引用
- Wang CM, Jia XP, Luo J, et al. [Clinical analysis of nine pediatric cases of acute myeloid leukemia with NUP98 rearrangement]. Zhonghua Xue Ye Xue Za Zhi. 2026. PMID: 42851181. doi:10.3760/cma.j.cn121090-20260319-00142
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。